로딩 중…
StockDiggingStockDigging

Illumina, Inc.

ILMN· NASDAQ
$198.40-3.27%
2026-08-03

Financials

Valuation Metrics

Illumina, Inc.'s Market Cap is $30.02B. At end of 2025 it was $20.07B. Ranked #463 of 3,112 in US market (top 15%), #137 of 1,445 on NASDAQ (top 9%), #31 of 206 in Health Care Equipment & Services (top 15%) by Market Cap.

Investment Metrics(as of 2026-08-03)

MetricValue
Size
Market Cap$30.02B
Revenue$4.39B
Net Income$853M
Total Assets$6.56B
Net Assets$2.68B
Employees8,600
Value
P/E35.19x
P/B11.22x
PEG15.37x
P/S6.84x
EV/EBITDA22.35x
FCF Yield3.29%
Profitability
ROE31.88%
ROA13.01%
Op. Margin21.45%
Revenue Growth4.80%
Earnings Growth2.29%
Financial Health
Debt Ratio145.10%
Total Debt$2.54B
FCF$989M
Cash$1.09B
Current Ratio1.75x
Net Debt/EBITDA1.03x
Performance
1Y Return109.59%
1M Return5.15%
From 52W High-4.15%
1Y MDD-25.66%
Trading
Volume2,237,149 shares
Trading Value$450M
Per Share
EPS$5.56
BPS$17.80

Company Info

CEO Mr. Jacob Thaysen Ph.D.
Employees 8,600
HQ San Diego, United States

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.